ListarFarmacología y Pediatría - (FP) por tema "Benralizumab"
Mostrando ítems 1-1 de 1
-
Real‑life cost‑effectiveness of benralizumab in patients with severe asthma.
Padilla‑Galo, A.; García-Ruiz, Antonio J.
; Levy Abitbol, R. Ch.; Olveira-Fuster, Casilda; Rivas‑Ruiz, F; García-Agua-Soler, Nuria; Pérez Morales, Marcel; Valencia Azcona, B.; Tortajada‑Goitia, B.; Moya‑Carmona, Isabel; Levy‑Naon, Alberto[et al.] (BMC, 2021-05-27)
The aim of this study was to evaluate clinical outcomes and healthcare expenditure after incorporating benralizumab into the standard treatment of refractory eosinophilic asthma. Methods: This was a cross-sectional ...